News
From regular exercise to eating well, there are many things you can do to protect your joints. Try these tips for healthy ...
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
Yoga and strengthening exercises both reduced knee pain in patients with knee ... The program was specifically designed for patients with arthritis, which may not have reflected the safety or ...
With improved knee strength, older adults can take control of their lives with better mobility. Check out these exercises for good joint health. As people grow old, their knee joints grow weaker ...
Among a large cohort of young adults with psoriatic arthritis, 38.8% exhibited radiographic evidence of degenerative disc disease. Researchers in Canada conducted a retrospective cohort study to ...
IL-23 is a cytokine secreted by activated monocyte/macrophages and dendritic cells that is known to be a driver of immune-mediated diseases including active psoriatic arthritis. In the phase 3b APEX ...
US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).
Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...
Psoriatic arthritis represents a complex intersection ... regimens focusing on joint protection principles, strengthening exercises, and range-of-motion preservation. Occupational therapy ...
Long-term extension data show Tremfya (guselkumab) significantly reduced symptoms and inhibited structural joint damage progression in patients with active psoriatic arthritis. Findings from the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results